HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
7.52
+0.12 (1.62%)
Apr 29, 2025, 4:00 PM EDT - Market closed
HCW Biologics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 4.67 | 3.6 | 22.33 | 11.73 | 8.46 | Upgrade
|
| Short-Term Investments | - | - | 9.74 | 24.98 | - | Upgrade
|
| Cash & Short-Term Investments | 4.67 | 3.6 | 32.06 | 36.71 | 8.46 | Upgrade
|
| Cash Growth | 30.03% | -88.79% | -12.67% | 334.19% | 14.95% | Upgrade
|
| Accounts Receivable | 0.58 | 1.54 | 0.42 | - | 2.5 | Upgrade
|
| Other Receivables | - | - | - | 0.13 | - | Upgrade
|
| Receivables | 0.58 | 1.54 | 0.42 | 0.13 | 2.5 | Upgrade
|
| Prepaid Expenses | 0.33 | 1.04 | 1.39 | 2.2 | 0.54 | Upgrade
|
| Other Current Assets | 0.11 | 0.23 | 0.2 | 1.44 | 0.65 | Upgrade
|
| Total Current Assets | 5.7 | 6.4 | 34.07 | 40.48 | 12.15 | Upgrade
|
| Property, Plant & Equipment | 22.91 | 20.45 | 10.8 | 1.12 | 1.62 | Upgrade
|
| Long-Term Investments | 1.6 | 1.6 | 1.6 | 11.52 | 1.6 | Upgrade
|
| Other Long-Term Assets | 0.03 | 0.06 | 0.33 | 0.39 | 0.03 | Upgrade
|
| Total Assets | 30.24 | 28.51 | 46.81 | 53.51 | 15.4 | Upgrade
|
| Accounts Payable | 22.33 | 6.17 | 1.23 | 0.22 | 0.16 | Upgrade
|
| Accrued Expenses | 0.98 | 2.43 | 1.55 | 0.3 | 0.28 | Upgrade
|
| Short-Term Debt | 6.31 | - | - | - | 0.57 | Upgrade
|
| Current Portion of Long-Term Debt | - | 0.12 | - | - | - | Upgrade
|
| Current Portion of Leases | - | 0.03 | 0.18 | - | - | Upgrade
|
| Current Unearned Revenue | - | - | - | 1.8 | - | Upgrade
|
| Total Current Liabilities | 29.63 | 8.75 | 2.96 | 2.32 | 1 | Upgrade
|
| Long-Term Debt | 7.38 | 6.3 | 6.41 | - | - | Upgrade
|
| Long-Term Leases | - | - | 0.01 | - | - | Upgrade
|
| Total Liabilities | 37.01 | 15.05 | 9.38 | 2.32 | 1 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 93.78 | 83.99 | 82.96 | 81.83 | - | Upgrade
|
| Retained Earnings | -100.56 | -70.53 | -45.54 | -30.64 | -16.72 | Upgrade
|
| Total Common Equity | -6.77 | 13.46 | 37.43 | 51.19 | -16.72 | Upgrade
|
| Shareholders' Equity | -6.77 | 13.46 | 37.43 | 51.19 | 14.4 | Upgrade
|
| Total Liabilities & Equity | 30.24 | 28.51 | 46.81 | 53.51 | 15.4 | Upgrade
|
| Total Debt | 13.69 | 6.45 | 6.6 | - | 0.57 | Upgrade
|
| Net Cash (Debt) | -9.02 | -2.86 | 25.46 | 36.71 | 7.89 | Upgrade
|
| Net Cash Growth | - | - | -30.65% | 365.41% | 7.24% | Upgrade
|
| Net Cash Per Share | -9.30 | -3.18 | 28.43 | 78.24 | 66.58 | Upgrade
|
| Filing Date Shares Outstanding | 1.12 | 0.95 | 0.9 | 0.89 | 0.12 | Upgrade
|
| Total Common Shares Outstanding | 1.11 | 0.9 | 0.9 | 0.89 | 0.12 | Upgrade
|
| Working Capital | -23.93 | -2.34 | 31.11 | 38.16 | 11.15 | Upgrade
|
| Book Value Per Share | -6.08 | 14.95 | 41.73 | 57.25 | -139.51 | Upgrade
|
| Tangible Book Value | -6.77 | 13.46 | 37.43 | 51.19 | -16.72 | Upgrade
|
| Tangible Book Value Per Share | -6.08 | 14.95 | 41.73 | 57.25 | -139.51 | Upgrade
|
| Land | 2.15 | 2.15 | 2.15 | - | - | Upgrade
|
| Buildings | 6.11 | 6.11 | 6.11 | - | - | Upgrade
|
| Machinery | 2.66 | 2.66 | 2.62 | 2.42 | 2.37 | Upgrade
|
| Construction In Progress | 13.55 | 10.44 | 0.05 | - | - | Upgrade
|
| Leasehold Improvements | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.